San Raffaele
| イタリア | トルコ | オーストリア | |
| 幹細胞治療 | から $30,000 | から $15,000 | から $40,000 |
Bookimedはアルツハイマー病治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。アルツハイマー病治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。アルツハイマー病治療の旅路でお一人になることはありません。
Dr. Enrico Motti performs over 500 Gamma Knife procedures per year at Maria Cecilia Hospital. He specializes in treating inoperable intracranial tumors, vascular lesions, and trigeminal neuralgia. Dr. Motti holds a patent for interfacing stereotaxic equipment with CT scanning methods. He coordinates the Gamma Knife unit at a JCI-accredited facility in Italy.
Italys premier Alzheimer's research and treatment hubs cluster in Milan and Rome. Milan centers like San Raffaele and Carlo Besta leading scientific innovation. These institutions hold Scientific Institute for Research and Healthcare (IRCCS) status. They offer advanced molecular diagnostics and experimental therapies for neurodegeneration.
Bookimed Expert Insight: Milan serves as Italy's primary neurological corridor with centers like San Raffaele treating 300,000 patients annually. For dementia, selecting a facility with IRCCS accreditation is vital. This government designation ensures the clinic combines clinical care with active research. This allows patients to access technologies like stem cell therapy for rare diseases. These methods are often unavailable at standard hospitals.
Patient Consensus: Patients note that while the public system offers high-quality care, waiting lists can reach 6 months. Many find that private consultations at university-affiliated centers provide faster access to memory clinics and clinical trials.
Evidence-based Alzheimer’s care in Italy centers on pharmacological management and advanced neurological research. Centers like San Raffaele Hospital offer drug therapies alongside stem cell research. Standard treatments include cholinesterase inhibitors and NMDA receptor antagonists. These help manage memory symptoms and cognitive decline effectively.
Bookimed Expert Insight: Italian IRCCS-accredited hospitals like San Raffaele and Ospedale Galeazzi prioritize integrated research. San Raffaele alone treats 300,000 patients annually and leads in stem cell innovation. Choosing an IRCCS facility ensures patients access academic-level neurology and experimental trials. These research centers offer higher technology standards than general private clinics.
Patient Consensus: Residents note that doctors strongly emphasize the Mediterranean diet alongside medication. Patients often find the initial diagnostic process thorough, focusing on bloodwork to rule out other conditions.
A full diagnostic work-up and initial treatment plan in Italy typically takes 5 to 10 business days. Private clinics often complete standard tests within 3 to 5 weekdays. International patients should plan for a total stay of 7 to 14 days to finalize specialized neurological protocols.
Bookimed Expert Insight: Milan serves as the primary hub for neurological evaluations in Italy. Clinics like San Raffaele and Santa Caterina da Siena integrate diagnostic imaging and lab analysis within single facilities. Our data shows that choosing centers with IRCCS accreditation ensures access to research-grade diagnostics. This often reduces the need for multiple specialty visits across different locations.
Patient Consensus: Patients note that private clinics in Milan offer much faster 2-week turnarounds compared to the public system. They emphasize pre-booking with records and confirming foreigner protocols upfront to prevent administrative delays.
Safety standards for Italian Alzheimer care include JCI accreditation and the Institutional Accreditation from regional health authorities. Look for IRCCS recognition from the Ministry of Health. This proves the center integrates clinical research with patient care. Facilities must also hold the Autorizzazione all Esercizio for safety compliance.
Bookimed Expert Insight: San Raffaele in Milan holds IRCCS accreditation and serves over 300,000 patients annually. This research status is a critical safety signal. It ensures patients access treatments developed alongside neurological research programs. High-volume centers often maintain better safety outcomes for complex cases. Large facilities like this offer over 18 specialized departments under one roof.
Patient Consensus: Patients value facilities with secure layouts that allow for safe movement. Many emphasize the importance of having multiple specialized neurologists and psychologists on the immediate care team.
Italy is a premier destination for early-stage Alzheimer’s trials. It hosts 450 specialized Centers for Cognitive Disorders and Dementia. Leading institutions like San Raffaele in Milan conduct international research. National projects like INTERCEPTOR focus specifically on biomarker models for early-stage patients.
Bookimed Expert Insight: While many countries focus solely on drug trials, Italy integrates family involvement into clinical protocols. Hospitals like San Raffaele emphasize research that includes family-integrated care models. This support often comes without co-pays for participants in the trial phase. These centers managed by high-volume networks provide access to advanced research while maintaining high patient ratings.
Patient Consensus: Patients note that while Italian trials offer exceptional support, fluency in Italian is often required for cognitive testing. Those without residency should check visa rules early due to documented bureaucratic complexity.
Italian memory clinics provide remote clinical support through telemedicine and structured follow-up programs. Facilities like San Raffaele Hospital offer 6-month medication regimens. Specialists coordinate with international doctors to manage prescriptions. Documentation is usually translated into English for seamless continuity of care.
Bookimed Expert Insight: Patients should prioritize private IRCCS-accredited research hospitals like San Raffaele for Alzheimer's care. These centers combine clinical practice with active research. Our data shows they often manage much higher patient volumes. For example, San Raffaele serves 300,000 patients annually and maintains 350 doctors. This high density of specialists ensures faster responses to international queries compared to smaller regional clinics.
Patient Consensus: Patients note that while email follow-ups are common, it is vital to confirm English support availability beforehand. Many travelers find that private portals make accessing translated medical reports much easier than using public hospital systems.
To accelerate an Alzheimer’s consultation in Italy, bring your national health card (Tessera Sanitaria), tax code (Codice Fiscale), and a valid ID or passport. A specific medical referral (Impegnativa) from a general practitioner is mandatory for accessing specialized neurological services in Italian medical centers.
Bookimed Expert Insight: Italian research hospitals like San Raffaele in Milan hold IRCCS status for combining clinical care with advanced research. This accreditation often gives patients earlier access to experimental protocols such as stem cell therapy for cognitive decline. Choosing an IRCCS-certified facility ensures the diagnostic process follows the latest national research standards.
Patient Consensus: Patients emphasize arriving early to handle paperwork as northern regions like Lombardia often use digital registration while others require physical stamps. Forgetting the tax code can delay the appointment by weeks, so keep photocopies of all administrative documents ready.
Diagnosis in Italy follows a multidisciplinary pathway at specialised Memory and Dementia Centres. Standard tests include neuropsychological batteries, structural brain imaging like MRI, and cerebrospinal fluid analysis. These clinical assessments differentiate Alzheimer's from other neurodegenerative conditions.
Bookimed Expert Insight: Italian research hospitals lead in neuro-diagnostic integration. San Raffaele in Milan serves 300,000 patients annually and maintains IRCCS accreditation. This designation gives patients access to diagnostic protocols that bridge standard care and research. This is essential for complex dementia cases.
Italy is currently evaluating lecanemab and donanemab for standard use. These disease-modifying drugs are not yet widely available. The Italian Medicines Agency (AIFA) is reviewing reimbursement. Access remains restricted to clinical trials or specialised research centres. This continues while infrastructure for administration is finalised.
Bookimed Expert Insight: Italian neurological care is concentrated in IRCCS-accredited research hospitals like San Raffaele. These centres serve 300,000+ patients annually and lead in experimental protocols. Patients seeking the latest therapies should focus on Milan or Rome. These cities house the nation's largest research infrastructures needed for these complex infusions.
Patient Consensus: Patients note that drug approval in Italy does not guarantee immediate access. Availability often depends on regional health decisions and specific memory clinic pathways. Many find the diagnostic work-up intensive and similar to a clinical trial.
Italy hosts elite Alzheimer's research centres, primarily Scientific Institutes for Research and Healthcare (IRCCS). Facilities like San Raffaele in Milan provide specialised neurological care. Patients access over 500 specialised cognitive disorder centres (CCDDs) nationwide for multidisciplinary assessment. Many leading hubs integrate university-led research with therapeutic innovation.
Bookimed Expert Insight: Italian neurology centres combine high surgical volumes with deep research foundations. San Raffaele alone performs over 52,000 operations yearly. It also pioneered the world's first stem cell therapy for immune disorders. Alzheimer's patients gain access to centres that quickly translate laboratory breakthroughs into clinical practice.
Patient Consensus: Patients value the multidisciplinary approach at Italian IRCCS facilities. They note that having diagnostic imaging and laboratory analysis on-site streamlines the assessment process.
Patients can participate in Alzheimer's clinical trials in Italy by visiting IRCCS-accredited research hospitals. These centres combine medical care with scientific research. Admission typically requires a referral from a neurologist at a specialised dementia centre. Italy hosts major trials for stem cell therapies and monoclonal antibodies.
Bookimed Expert Insight: Italian IRCCS centres offer a distinct advantage. They must legally integrate research into daily clinical practice. San Raffaele, for example, serves 300,000 patients annually. It leads European research in cellular therapies. Patients should prioritise these large research hospitals. They often run multiple concurrent trials that smaller private clinics cannot support.
Italy provides home care for Alzheimer's patients through the National Health Service (SSN) and the private sector. Public support includes Individualised Care Plans (PAI) and specialised diagnostic assessments. Families often hire private caregivers, known locally as badanti, for daily personal care and nursing assistance.
Bookimed Expert Insight: Italy has established neurological centres like San Raffaele in Milan. However, public home care availability varies by region. Families often find more funded services in northern Italy. Patients should confirm if neuro-rehabilitation includes structured home visits before starting treatment.
Patient Consensus: Patients say it is vital to confirm if home-care providers offer English-speaking staff. They also emphasise checking if services cover medication management and family training.